Neuronetics, Inc. (Neuronetics) is a medical device company engaged in the development of innovative therapies for psychiatric and neurological disorders. It develops brain stimulation products using therapeutic neuromodulation technology for the neurology markets. The company`s major product is the NeuroStar TMS (Transcranial Magnetic Stimulation) therapy system which is used for the treatment of depression. It uses repetitive electromagnetic pulses that are directly targeted at the left prefrontal cortex of the brain and produces a stimulus in the brain which causes positive changes in mood. The company also develops Practice Data Management System (PDMS) and SenStar Treatment Link. The company is headquartered in Pennsylvania, the US.